… of 12 months of treatment with romosozumab … effects of one-year romosozumab treatment
by investigating its actual clinical effects, adverse effects, and factors influencing the effects of …

… 1 year of romosozumab … romosozumab treatment for osteoporosis with a high risk of fractures
and the TRACP 5b value before romosozumab administration was a significant predictor of …

… of previous treatment. In this study, we investigated whether the effectiveness of 12 months
of romosozumab treatment depended on the duration of osteoporosis previous treatment. …

… The aims of the study were two-fold: (1) to further elucidate the effects of 12 months of treatment
with romosozumab by investigating its actual clinical effects, adverse events, and factors …

… that prior antiresorptive treatment (such as BP or DMAb) may diminish the effects of ROMO,
… clarify the effects of prior treatment and determine predictors for early treatment response of …

… treatment sequence affects romosozumab response, this analysis reviewed studies where
romosozumab … Initial treatment with romosozumab followed by an antiresorptive resulted in …

… In this study, we aim to clarify the effects of prior treatment and to determine the early
predictors of the 12-month treatment response of ROMO in patients with postmenopausal …

… (g/cm 2 ) after romosozumab treatment, expressed as the percentage of the … romosozumab
treatment, we performed linear regression that first includes only romosozumab treatment as …

… the progress, safety, and effects of romosozumab treatment of osteoporosis in a university
… effects of romosozumab treatment by investigating the actual clinical effects, adverse effects, …

… predictors of nonresponse to romosozumab treatment. Clinicians could use these predictors
… ’s likelihood of nonresponse to romosozumab, improving osteoporosis treatment outcomes. …